Arix Bioscience Valuation
Is 3HY undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3HY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 3HY's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 3HY's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3HY?
Key metric: As 3HY is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 3HY's PE Ratio? | |
|---|---|
| PE Ratio | 11.8x |
| Earnings | UK£14.96m |
| Market Cap | UK£176.52m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5.3x |
| Enterprise Value/EBITDA | 9.1x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 3HY's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 14.4x | ||
BBHK Deutsche Balaton | 5.9x | n/a | €175.4m |
MPCK MPC Münchmeyer Petersen Capital | 12.2x | 5.4% | €204.4m |
DBAN Deutsche Beteiligungs | 24.2x | 54.1% | €417.2m |
O4B OVB Holding | 15.3x | 3.5% | €283.6m |
3HY Arix Bioscience | 11.8x | n/a | €176.5m |
Price-To-Earnings vs Peers: 3HY is good value based on its Price-To-Earnings Ratio (11.8x) compared to the peer average (22.8x).
Price to Earnings Ratio vs Industry
How does 3HY's PE Ratio compare vs other companies in the DE Capital Markets Industry?
| 4 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
AR4 AURELIUS Equity Opportunities SE KGaA | 3.9x | n/a | US$413.77m |
HXCK Ernst Russ | 3.7x | -18.2% | US$205.53m |
VG8 Varengold Bank | 1.9x | n/a | US$24.20m |
XE8 Black Sea Property | 0.7x | n/a | US$7.73m |
| 4 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 3HY is good value based on its Price-To-Earnings Ratio (11.8x) compared to the German Capital Markets industry average (23.2x).
Price to Earnings Ratio vs Fair Ratio
What is 3HY's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 11.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 3HY's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Pepper Money
AU$581.0m
Operates as a non-bank lender in the mortgage and asset finance markets in Australia and New Zealand.
X95
AU$0.80
7D
-1.9%
1Y
13.6%
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
OIX
JP¥20.40
7D
0%
1Y
22.9%
Yeahka
HK$4.2b
An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.
4YE
HK$1.18
7D
-6.3%
1Y
-27.2%